Peptide TherapyPhysician-Supervised Regenerative Medicine

Safety depends on the specific peptide, your individual health profile, and the quality of medical oversight. When prescribed by a CPSBC-licensed physician like Dr. Jiang and dispensed by a Health Canada licensed compounding pharmacy, peptide therapy operates within a structured medical framework. That said, not all peptides have equivalent safety data: semaglutide (GLP-1) has extensive clinical trial evidence; GH-releasing peptides have a reasonable safety record under supervision; BPC-157 and similar compounded peptides have limited human trial data. Contraindications — including cancer history and certain cardiovascular conditions — are assessed before any prescription is written.

Most peptides used in Dr. Jiang's protocols are administered by subcutaneous injection using a fine insulin-gauge needle. The clinic provides hands-on training before you self-administer at home. Some peptides are available as oral capsules or topical creams where clinically appropriate. Injection frequency is determined by the specific protocol — daily, several times per week, or on a cycle schedule — and is reviewed at each monitoring visit.

Direct HGH injection bypasses the pituitary's own regulatory feedback, which can suppress natural GH production over time and carries risks including fluid retention, joint pain, and potential oncological concerns. GH-releasing peptides like Ipamorelin and Sermorelin stimulate the pituitary to release its own GH in pulses, preserving the natural feedback loop. Anabolic steroids introduce synthetic androgens that can cause significant hormonal disruption, cardiovascular risk, and suppression of natural testosterone production. Peptide therapy used under physician supervision operates through endogenous signalling pathways — a meaningfully different risk profile, though not risk-free.

Combining protocols is clinically possible and is one of RAAC's integrative strengths. GHK-Cu, for example, may enhance skin's collagen response to energy-based treatments like Thermage or Ultherapy. Any combination protocol is reviewed by Dr. Jiang to ensure there are no contraindications or timing conflicts between treatments.

Duration of benefit varies by peptide. GLP-1 (semaglutide) effects on appetite regulation typically diminish after discontinuation; weight management benefits require ongoing use or a maintenance strategy. GH-related changes in body composition and sleep may persist for weeks to months after a completed cycle, depending on the patient's baseline. Dr. Jiang discusses post-cycle maintenance and tapering at each cycle review.

Common and generally mild: injection site reactions (redness, swelling, bruising), transient water retention in GH-releasing protocols, and initial fatigue or appetite changes. GLP-1 side effects include nausea and GI discomfort, especially early in titration. Serious side effects are uncommon but monitored through quarterly blood work. Specific peptides carry specific risks — discussed at consultation and reviewed at each cycle check.